Our Recommendations
- Antimicrobial Resistance National Strategy Framework 2014 –2024 (South Africa) (2015)
- Standards for the Establishment and Operations of Model Pharmacies and Model Medicine Shops (2016)
- Malawi Standard Treatment Guidelines (MSTG) 5th Edition (2015)
- National Medicines Policy 2015 (2015)
- Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia) (2011)
New Publications
- The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review (2022)
- Guide for Pharmacists (2022)
- Liste nationale des médicaments essentiels et autres produits de santé (2023) (2023)
- Liste Nationale des Médicaments et autres produits de Santé Essentiels 2022 du Tchad (2023)
- Access to controlled medicines for pain management in the WHO South-East Asia Region (2023)
Filter
426
Featured
Recommendations
27
New Publications
133
Language
Document type
No document type
253
Guidelines
71
Studies & Reports
52
Fact sheets
13
Strategic & Response Plan
11
Manuals
8
Resource Platforms
7
Infographics
5
Videos
3
Training Material
2
Brochures
1
Countries / Regions
Ethiopia
32
Kenya
24
Uganda
23
South Africa
22
Rwanda
20
India
20
Nepal
17
Nigeria
17
Indonesia
15
Burkina Faso
13
Malawi
13
Zimbabwe
13
Bangladesh
13
Ghana
12
Chile
12
Tanzania
12
Zambia
12
Haiti
11
Ukraine
9
Benin
9
Botswana
9
Sierra Leone
8
Namibia
7
Lesotho
6
Bolivia
6
Myanmar / Burma
6
Senegal
5
Congo, Democratic Republic of
5
Paraguay
5
Liberia
5
Eswatini/ Swaziland
5
Philippines
4
Latin America and the Carribbean
4
Eastern Europe and Central Asia
4
Argentina
4
Central African Republic
4
Colombia
3
Global
3
West and Central Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Madagascar
3
Mozambique
2
Cambodia
2
Germany
2
United Kingdom
2
East and Southern Africa
2
North Macedonia
1
Tajikistan
1
Thailand
1
Serbia
1
Australia
1
China
1
Kazakhstan
1
Syria
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Malaysia
1
Armenia
1
Africa
1
Guinea-Bissau
1
Venezuela
1
South–East Asia Region
1
Brazil
1
Russia
1
Sudan
1
Georgia
1
Angola
1
Chad
1
Libya
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Toolboxes
Essential Medicines & Devices Lists
25
Country specific
12
Reports & Studies
9
Country specific documents
6
Essential Medicines
6
Pharmacy Practice
6
Quality Assurance
6
Clinical Guidelines
5
Essential Medicines & Medical Devices
5
Pharmacovigilance
4
Waste Managment
4
Country Specific
3
Pharmacy Management
3
Rational use of Medicine
3
Resource Platforms
3
Guidelines & Manuals
3
Surveillance
2
International
2
Studies
2
Essential List
2
Falsified & Substandard
2
Medicine Donations
2
Pharmaceutical Assessments
2
Traditional & Herbal Medicines
2
General Guidelines for Rational Use
2
General
1
PPE Personel Protective Equipment
1
Diagnostics & Laboratory Guidance
1
Global Impact: Socio-economic, health services, TB & HIV
1
Access & Strategy
1
Dashboards & Resource Platforms
1
Logistics & Supply
1
Videos
1
Pharmacy
1
Prices and Patents
1
Model Formulary
1
Supply Chain & Store Management
1
Women & Maternal Health
1
Argentina
1
Various Target Groups
1
Videos
1
Health Care Systems
1
General
1
Emergency health kits
1
Chagas
1
Overview, Studies & Reports
1
Capacity Building & Resources
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Assessment & Response
1
Malawi
1
Uganda
1
Stewardship
1
General Public
1
Assessment
1
n the countries of the Region of the Americas, there are different forms of organization of health services at the first level of care. Some countries include certain laboratory, dental and diagnostic imaging practices in the first level of care, while other countries centralize these practices in t...
La Organización Panamericana de la Salud publica la tercera versión de la lista de dispositivos médicos prioritarios (LDMP) para el primer nivel de atención, elaborada de acuerdo con la realidad epidemiológica de los países de la Región de las Américas y adaptada al contexto de la pandemia d...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la prévention et le traitement ...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
Die Liste wird kontinuierlich aktualisiert und beinhaltet die entsprechenden Tests zur professionellen Anwendung, die sich nach aktueller Kenntnis des BfArM in Deutschland in Verkehr befinden und laut den Herstellerangaben die jeweils aktuellen durch das Paul-Ehrlich-Institut (PEI) in Abstimmung mit...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
